Cite

HARVARD Citation

    Lock, R. et al. (n.d.). Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the pediatric preclinical testing program1. Pediatric blood & cancer. 60 (7), pp. E42-E45. [Online]. 
  
Back to record